effe, appreciate your enthusiasm about the technical, but upcoming news is the binary event.. all the technical and the current trends are meaningless..
if data is marginal or no good, I think many lawsuits will be followed due to many "bait 'n switch" actions by the CLDN leaderships like MFG's agreement, secondary announcement, CEO promising "exciting data" and the recent CEO's stock selling which signalling the checkpoint data is better than expectations.
I'm hopeful that P2 data is similar or better than P1 data, and get fast track approval by the FDA to make this drug available to the market ASAP... It is a difficult problem to solve, so it could go either way at this stage.. GL longs..
here's my thoughts about your 2000 buy premarket orders didn't get filled.
1. Do you have enough $ in your cash account ?
2. Did you place as AON or limit order in pre-market?
3. Have you ever get your orders filled during the normal trading hours ?
4. Many brokerages do not allow limit or AON orders in pre-market.
5. You can easily call them up and ask for an explanation, instead of asking question in the YMB.
if all the shorts are leaning on one side of the boat, I would bet that the boat will capsize soon.. Short some more so you can cover at higher prices later... GL
Sentiment: Strong Buy
I think CEO mentioned Cupid 3 as a precautionary (the worse case), so she won't get sued for misleading investors (layout all the possible scenarios, just in case FDA wants to see larger sample size to validate the previous studies)..
looks like they're preparing to ramp up production with MFG agreement ( why waste time/resources if data is marginal or STATISTICAL IN-SIGNIFICANT ). GL longs..
rfw, well said.. I like the way you laid out the probability of the good news which is expected by the activities led to this point ..the major obstacle is the checkpoint is statistical significant and P value is less than .005.. I am hopeful this is the case.. GL
singkumbaya, did you miss this paragraph or selectively ignored:
CUPID 1: Double-Blind, Randomized, Placebo Controlled Trial
if the sample is randomized, then who care how many patients had previous MI ?
bio, you neither long or short, why are you here ? all you have is a big mouth with a small brain..
nobody is interested in listening 3 yrs olds cryin'.. grow up little girl...
in addition to looking forward to releasing next checkpoint, deal signed with MFG to ramp up production is a good indication of the preparation to get FDA approval and make drugs available to the market..
if CLDN management releases negative news 4 weeks from now, this company is doomed, many lawsuits will be filed for using bait-n-switch tactic to deceive investors.. GL longs..
biotech, why speculate when you have no dog in this fight ? too much time in your hand ? get a day job ..
I had similar thoughts about the probability of positive outcome for the upcoming checkpoint.. if CLDN management knows the results were not statistical significant but creating false impression by signing the MFG deal with Novasep, then many lawsuits will be filed and CLDN is doomed. GL
MFG production deal announcement and upcoming clinical trials updates should be stablizing SP by now.. looks like insiders have been unloading shares for the past 3 months.. Don't know if I should hang on to my share until the announcement or cut my loss and leave town.. well, I may tough it out and see the light at the end of the tunnel..
should hold until May/June time frame after the clinical trial update.. you may want to consider lock in 1/2 of your profit before the announcement, let it ride the rest... GL